Ashutosh Dhingra

Ashutosh Dhingra is a Researcher at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, Germany, specializing in cellular and molecular neuroscience with a focus on neurodegenerative disorders. He holds a Master of Science in Cellular and Molecular Neuroscience and has established himself as a significant contributor to research on frontotemporal dementia, Parkinson's disease, and stem cell-based disease modeling.

His educational background includes a Master's Student position at the Hertie-Institute for Clinical Brain Research in Tübingen, Germany (2009-2010), followed by a Marie Curie Fellow ESR position at VU University Amsterdam, VUMC, Netherlands (2010-present).

Dhingra's research focuses on understanding the molecular mechanisms underlying neurodegenerative diseases using induced pluripotent stem cell (iPSC) technology. His work particularly examines C9orf72-related pathologies in ALS and frontotemporal dementia, tauopathies associated with MAPT mutations, and lysosomal dysfunction in Parkinson's disease. He has developed expertise in stem cell differentiation, CRISPR-based screening technologies, and multi-omics approaches to study disease mechanisms.

Analysis of his recent publications reveals a strong emphasis on using patient-derived iPSC models to investigate cellular and molecular pathologies in neurodegenerative conditions. His work spans from basic molecular mechanisms (like the regulation of β-glucocerebrosidase in Parkinson's disease) to translational research (drug screening in iPSC-neuron models). A notable trend is his increasing focus on non-neuronal cells like microglia and oligodendrocytes in neurodegeneration, reflecting the evolving understanding of these diseases.

• Marie Curie Fellow

Dhingra has been actively involved in multiple collaborative research projects, particularly within the RiMod-FTD consortium focused on frontotemporal dementia. His technical expertise includes stem cell culture, CRISPR screening, and multi-omics analysis. While specific grant details aren't provided in the text, his Marie Curie Fellowship indicates successful competitive grant acquisition. His research has generated significant interest with over 10,000 reads and 868 citations across his 27 publications.

At DZNE, Dhingra works within research teams focused on neurodegenerative disease mechanisms, collaborating extensively with experts in various fields including Bryan Traynor at NIH, Peter Heutink, and other prominent neuroscientists across Europe. His work contributes to the broader efforts at DZNE to understand and develop treatments for neurodegenerative conditions.